China’s Covid-19 vaccine induces antibody response

China’s Covid-19 vaccine induces antibody response

The coronavirus vaccine candidate of China -- BBIBP-CorV -- is effective and safe to consume. The study, published in the journal Lancet Infectious Diseases, has found that the antibody responses were demonstrated by all participants between 18 to 80 years. Study author Xiaoming Yang from the Beijing Institute of Biological Products Company Limited in China said in a statement: "Protecting older people is a key aim of a successful Covid-19 vaccine as this age group is at greater risk of severe illness from the disease".

Read more at 
www.thehindubusinessline.com

Timeline

.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........

In-depth coverage

Read more top Science stories on Crisp